BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22898872)

  • 1. Slow development of ALS-like spinal cord pathology in mutant valosin-containing protein gene knock-in mice.
    Yin HZ; Nalbandian A; Hsu CI; Li S; Llewellyn KJ; Mozaffar T; Kimonis VE; Weiss JH
    Cell Death Dis; 2012 Aug; 3(8):e374. PubMed ID: 22898872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The homozygote VCP(R¹⁵⁵H/R¹⁵⁵H) mouse model exhibits accelerated human VCP-associated disease pathology.
    Nalbandian A; Llewellyn KJ; Kitazawa M; Yin HZ; Badadani M; Khanlou N; Edwards R; Nguyen C; Mukherjee J; Mozaffar T; Watts G; Weiss J; Kimonis VE
    PLoS One; 2012; 7(9):e46308. PubMed ID: 23029473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A progressive translational mouse model of human valosin-containing protein disease: the VCP(R155H/+) mouse.
    Nalbandian A; Llewellyn KJ; Badadani M; Yin HZ; Nguyen C; Katheria V; Watts G; Mukherjee J; Vesa J; Caiozzo V; Mozaffar T; Weiss JH; Kimonis VE
    Muscle Nerve; 2013 Feb; 47(2):260-70. PubMed ID: 23169451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A robust TDP-43 knock-in mouse model of ALS.
    Huang SL; Wu LS; Lee M; Chang CW; Cheng WC; Fang YS; Chen YR; Cheng PL; Shen CJ
    Acta Neuropathol Commun; 2020 Jan; 8(1):3. PubMed ID: 31964415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The heterozygous R155C VCP mutation: Toxic in humans! Harmless in mice?
    Clemen CS; Winter L; Strucksberg KH; Berwanger C; Türk M; Kornblum C; Florin A; Aguilar-Pimentel JA; Amarie OV; Becker L; Garrett L; Hans W; Moreth K; Neff F; Pingen L; Rathkolb B; Rácz I; Rozman J; Treise I; Fuchs H; Gailus-Durner V; de Angelis MH; Vorgerd M; Eichinger L; Schröder R
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2770-2777. PubMed ID: 30100055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactivity of valosin-containing protein in sporadic amyotrophic lateral sclerosis and in a case of its novel mutant.
    Ayaki T; Ito H; Fukushima H; Inoue T; Kondo T; Ikemoto A; Asano T; Shodai A; Fujita T; Fukui S; Morino H; Nakano S; Kusaka H; Yamashita H; Ihara M; Matsumoto R; Kawamata J; Urushitani M; Kawakami H; Takahashi R
    Acta Neuropathol Commun; 2014 Dec; 2():172. PubMed ID: 25492614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis.
    Nalbandian A; Donkervoort S; Dec E; Badadani M; Katheria V; Rana P; Nguyen C; Mukherjee J; Caiozzo V; Martin B; Watts GD; Vesa J; Smith C; Kimonis VE
    J Mol Neurosci; 2011 Nov; 45(3):522-31. PubMed ID: 21892620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disulfide cross-linked multimers of TDP-43 and spinal motoneuron loss in a TDP-43
    Bargsted L; Medinas DB; Martínez Traub F; Rozas P; Muñoz N; Nassif M; Jerez C; Catenaccio A; Court FA; Hetz C; Matus S
    Sci Rep; 2017 Oct; 7(1):14266. PubMed ID: 29079747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
    Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
    Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy.
    Turner BJ; Bäumer D; Parkinson NJ; Scaber J; Ansorge O; Talbot K
    BMC Neurosci; 2008 Oct; 9():104. PubMed ID: 18957104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mislocalization of TDP-43 in the G93A mutant SOD1 transgenic mouse model of ALS.
    Shan X; Vocadlo D; Krieger C
    Neurosci Lett; 2009 Jul; 458(2):70-4. PubMed ID: 19379791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor neuron translatome reveals deregulation of SYNGR4 and PLEKHB1 in mutant TDP-43 amyotrophic lateral sclerosis models.
    Marques RF; Engler JB; Küchler K; Jones RA; Lingner T; Salinas G; Gillingwater TH; Friese MA; Duncan KE
    Hum Mol Genet; 2020 Sep; 29(16):2647-2661. PubMed ID: 32686835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wild type human TDP-43 potentiates ALS-linked mutant TDP-43 driven progressive motor and cortical neuron degeneration with pathological features of ALS.
    Mitchell JC; Constable R; So E; Vance C; Scotter E; Glover L; Hortobagyi T; Arnold ES; Ling SC; McAlonis M; Da Cruz S; Polymenidou M; Tessarolo L; Cleveland DW; Shaw CE
    Acta Neuropathol Commun; 2015 Jun; 3():36. PubMed ID: 26108367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C57BL/6J congenic Prp-TDP43A315T mice develop progressive neurodegeneration in the myenteric plexus of the colon without exhibiting key features of ALS.
    Hatzipetros T; Bogdanik LP; Tassinari VR; Kidd JD; Moreno AJ; Davis C; Osborne M; Austin A; Vieira FG; Lutz C; Perrin S
    Brain Res; 2014 Oct; 1584():59-72. PubMed ID: 24141148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS-FTD-linked UBQLN2 mutations.
    Le NT; Chang L; Kovlyagina I; Georgiou P; Safren N; Braunstein KE; Kvarta MD; Van Dyke AM; LeGates TA; Philips T; Morrison BM; Thompson SM; Puche AC; Gould TD; Rothstein JD; Wong PC; Monteiro MJ
    Proc Natl Acad Sci U S A; 2016 Nov; 113(47):E7580-E7589. PubMed ID: 27834214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective Motor Neuron Resistance and Recovery in a New Inducible Mouse Model of TDP-43 Proteinopathy.
    Spiller KJ; Cheung CJ; Restrepo CR; Kwong LK; Stieber AM; Trojanowski JQ; Lee VM
    J Neurosci; 2016 Jul; 36(29):7707-17. PubMed ID: 27445147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.
    Mackenzie IR; Bigio EH; Ince PG; Geser F; Neumann M; Cairns NJ; Kwong LK; Forman MS; Ravits J; Stewart H; Eisen A; McClusky L; Kretzschmar HA; Monoranu CM; Highley JR; Kirby J; Siddique T; Shaw PJ; Lee VM; Trojanowski JQ
    Ann Neurol; 2007 May; 61(5):427-34. PubMed ID: 17469116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TDP-43 in the hypoglossal nucleus identifies amyotrophic lateral sclerosis in behavioral variant frontotemporal dementia.
    Halliday GM; Kiernan MC; Kril JJ; Mito R; Masuda-Suzukake M; Hasegawa M; McCann H; Bartley L; Dobson-Stone C; Kwok JBJ; Hornberger M; Hodges JR; Tan RH
    J Neurol Sci; 2016 Jul; 366():197-201. PubMed ID: 27288806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial defect in muscle precedes neuromuscular junction degeneration and motor neuron death in CHCHD10
    Genin EC; Madji Hounoum B; Bannwarth S; Fragaki K; Lacas-Gervais S; Mauri-Crouzet A; Lespinasse F; Neveu J; Ropert B; Augé G; Cochaud C; Lefebvre-Omar C; Bigou S; Chiot A; Mochel F; Boillée S; Lobsiger CS; Bohl D; Ricci JE; Paquis-Flucklinger V
    Acta Neuropathol; 2019 Jul; 138(1):123-145. PubMed ID: 30874923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An autopsy report of a familial amyotrophic lateral sclerosis case carrying VCP Arg487His mutation with a unique TDP-43 proteinopathy.
    Matsubara T; Izumi Y; Oda M; Takahashi M; Maruyama H; Miyamoto R; Watanabe C; Tachiyama Y; Morino H; Kawakami H; Saito Y; Murayama S
    Neuropathology; 2021 Apr; 41(2):118-126. PubMed ID: 33415820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.